Atopic Dermatitis Therapeutics Market To Reach US$ 29.5 Billion By 2033 Driven By Biologics, Targeted Immunotherapies, And Rising Pediatric Diagnosis Rates Astute Analytica

(MENAFN - GlobeNewsWire - Nasdaq) Chronic and highly burdensome, atopic dermatitis affects an estimated 223 million people worldwide, with onset commonly occurring in infancy and childhood. Rising ...